Impact of tissue factor expression and administration routes on thrombosis development induced by mesenchymal stem/stromal cell infusions: re-evaluating the dogma
Abstract Background Hyperactive coagulation might cause dangerous complications such as portal vein thrombosis and pulmonary embolism after mesenchymal stem/stromal cell (MSC) therapy.Tissue factor (TF), an initiator of the extrinsic coagulation pathway, has been suggested as a predictor of this process.Methods The expression of TF and other pro- a